维普期刊资源整合服务平台（V6.5）

95篇 您的检索式：作者名="Tabemero"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Accomplishments in 2008 in the treatment of advanced metastatic colorectal cancer 显示文摘	Goldberg RM Meropol NJ Tabemero J	2009	Castrointest Cancer Res2009，3，2：	1
2	Activation of the peroxisome proliferatoractivated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation显示文摘	Tabemero A Schoonjans K Jesel L etal	2002	BMC Phannacol2002，2，：	1
3	Phase IlI trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer :A planned safety analysis in 1,864 patients 显示文摘	Schmoll H J Cartwright T Tabemero J	2007	J Clin On- col2007，25，：	1
4	COX-2 and inducible nitric oxide synthase in omental arteries harvested from pateints with severe liver disease: immuno-localization and influence on vascular tone显示文摘	Tabemero A Schneider F Potenza M A	2003	Intensive Care Med2003，29，：	1
5	Oxaliplatin/ 5FU/LV in adjuvant colon cancer : safety results of the international randomized MOSAIC trial显示文摘	de Gramont A Boni C Navarro M Tabemero J	2002	Proc Am Soc Clin Oncol2002，21，：	1
6	XELOX(capeeit- abine plus oxaliplatin) : Active first-line therapy for patients with meta-static colorectal cancer显示文摘	Caasidy J Tabemero J Twelves C	2004	J Clin Oncol2004，22，11：	1
7	Weekly docetaxel in breast cancer: applying clinical data to patient therapy 显示文摘	Baselga J Tabemero JM	2001	Oncologist2001，6，3：	1
8	XELOX ( capecitabine plus oxaliplatin ): active first-line therapy for patients with metastatic colorectal cancer 显示文摘	Cassidy J Tabemero J Twelves C	2004	J Clin Oncol2004，22，11：	1
9	Aurora kinase family: a new target for anticancer drug显示文摘	Macarulla T Ramos FJ Tabemero J	2008	Recent Pat Anticancer Drug Discov2008，3，2：	1
10	Phase Ⅲ trial of capecitahine plus oxallplatin as adjuvant therapy for stage Ⅲ colon cancer: a planned safety analysis in 1,864 patients显示文摘	Schmoll HJ Cartwfight T Tabemero J	2007	J Clin Oncol2007，25，1：	1
11	Safety profile and preliminary efficacy of capecitabine (Xeloda) in combination with oxoliplatin m patients with advanced or metastatic solid tumouts: Results from a phase I study 显示文摘	Evans J Tabemero J Cassidy J	2000	Ann Onco2000，11，4：	1
12	Proliferation of C6 glionm cells is blunted by the increase in gap junction communication caused by tolbutamide 显示文摘	Sanchez Alvarez R Tabemero A Sanchez Abarca LI	2001	FEBS Lett2001，509，2：	1
13	Establishing Practical Approach For Design consistency Evluation 显示文摘	Hassan Y Sayed T Tabemero V	2001	Journal of Transportation Engineering2001，4，：	1
14	Targeting the PI3K/Akt/mTOR pathway-beyond rapalogs 显示文摘	Markman B Dienstmann R Tabemero J	2010	Oncotarget2010，1，7：	1
15	A phase Ⅰ pharmacokinetic and pharmacodynamic study of weekly 1-hour and 24-hour infusion BMS- 214662,a farnesyltransferase inhibitor, in patients with advanced solid tumors显示文摘	Tabemero J Rojo F Marim6n I	2005	J Clin Oncol2005，23，10：	1
16	XELOX (Capecitabine plus oxaliplatin):active first-line therapy for patients with metastatic colorectal cancer显示文摘	Cassidy J Tabemero J Twelves C		0，，11：	1
17	A randomized, placebo-controlled phase 2 study of ganitumab or cona- aunumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer 显示文摘	Cohn AL Tabemero J Maurel J	2013	Ann Oncol2013，24，7：	1
18	Crystal structrue of a statin bound to a class II Hydroxymethylgtutaryl- CoA Reductase 显示文摘	Tabemero L Rodwell VW Stauffacher CV	2003	J Biochem2003，278，19：	1
19	Numerical simulation and experiment validation of power flux distribution in coaxial laser cladding 显示文摘	Tabemero A Lamikiz E Ukar	2010	Journal of Materials Processing Technology2010，，210：	1
20	Capecitabine plusoxaliplatin compared with fluorouracil and folinic acid asadjuvant therapy for stage K colon cancer 显示文摘	Haller DG Tabemero J Maroun J	2011	J Clin Oncol2011，29，：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示